SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines informs about closure of trading window

28 Oct 2016 Evaluate

Norris Medicines has informed that a meeting of the Board of Directors of the Company is scheduled to be held on November 08, 2016, to consider and approve, Unaudited Financial Results for the Quarter and Six months ended on September 30, 2016. Further, in accordance with Company’s Code of Conduct for Prevention of Insider Trading, the Trading window for dealing in the securities of the Company will be closed for all directors, and designated personnel of the Company from October 28, 2016 till November 10, 2016.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

14.97 0.22 (1.49%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×